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Abstract 
 
Aims: This study evaluated the impact of applying computerised outcome 
feedback (OF) technology in a stepped care psychological service offering low 
and high intensity therapies for depression and anxiety. 
Methods: A group of therapists were trained to use OF based on routine 
outcome monitoring using depression (PHQ-9) and anxiety (GAD-7) 
measures. Therapists regularly reviewed expected treatment response 
graphs with patients and discussed cases that were “not on track” in clinical 
supervision. Clinical outcomes data were collected for all patients treated by 
this group (N = 594), six months before (controls = 349) and six months after 
the OF training (OF cases = 245). Symptom reductions in PHQ-9 and GAD-7 
were compared between controls and OF cases using longitudinal multilevel 
modelling. Treatment duration and costs were compared using MANOVA. 
Qualitative interviews with therapists (N = 15) and patients (N = 6) were 
interpreted using thematic analysis. 
Results: OF technology was generally acceptable and feasible to integrate in 
routine practice. No significant between-group differences were found in 
post-treatment PHQ-9 or GAD-7 measures. However, OF cases had 
significantly lower average duration and cost of treatment compared to 
controls. 
Conclusions: After adopting OF into their practice, this group of therapists 
attained similar clinical outcomes but within a shorter space of time and at 
a reduced average cost per treatment episode. We conclude that OF can 
improve the efficiency of stepped care. 
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1. Introduction 
 
Several studies have demonstrated that monitoring patients’ response 
to psychological treatment using standardised outcome measures can help 
to detect difficulties and to improve outcomes for patients (Gondek, 
Edbrooke-Childs, Fink, Deighton, & Wolpert, 2016). Routine outcome 
monitoring may be particularly important for certain patients that tend to 
have a poorer response to treatment (Lambert, Hansen, & Finch, 2001; Lutz, 
De Jong, & Rubel, 2015), referred to as ‘signal cases’ or cases that are ‘not 
on track’ (NOT). Lambert et al. (2003) proposed that providing timely 
feedback to therapists using psychometric measures to alert them about 
signal cases could help to improve their outcomes. Typically, outcome 
feedback (OF) involves entering a patient’s symptom measures into a 
computer system that graphically displays changes from session-to-session, 
comparing these to clinical norms derived from hundreds of similar cases. 
Patients with symptoms that do not improve as suggested by these clinical 
norms are flagged up as NOT. A meta-analysis of controlled trials in USA 
concluded that NOT cases in usual psychological care were 2.3 times more 
likely to deteriorate by comparison to NOT cases treated by therapists that 
apply OF technology (Shimokawa et al., 2010). However, this meta-analysis 
included studies from the same research group which predominantly treated 
student populations, therefore raising some questions about generalizability 
(Davidson, Perry, & Bell, 2015). More recently, trials in European countries 
have replicated these findings in other clinical populations, suggesting that 
using OF can help to prevent deterioration in NOT cases (e.g., Amble, Gude, 
Stubdal, Andersen, & Wampold, 2015; De Jong et al., 2014; Hansson, 
Rundberg, Österling, Öjehagen, & Berglund, 2013). 
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Although the usefulness of outcome feedback has been demonstrated 
in specialist counselling and psychotherapy centres, these methods have not 
yet been tested in stepped care psychological services such as those linked 
to the IAPT (Improving Access to Psychological Therapies) model applied in 
England (Clark, 2011) and Australia (Cromarty, Drummond, Francis, 
Watson, & Battersby, 2016). IAPT services are particularly well placed to 
apply OF methods since they routinely collect standardised outcome 
measures at every session to monitor clinical outcomes (Clark, 2011). 
However, the high volume of work and time pressures typical of public 
healthcare settings may limit therapists’ ability to consistently and 
meaningfully reflect on the results of outcome measures within their 
treatment sessions. Furthermore, research suggests that IAPT clinicians do 
not necessarily consider symptom measures in their decisions about 
treatment planning and some tend to rely on subjective beliefs and attitudes 
when making decisions about the treatment of non-improving patients 
(Delgadillo, Gellatly, & Stephenson-Bellwood, 2015). Therefore, there are 
plausible contextual and attitudinal barriers that may limit the effective 
utilization of outcome feedback in this setting. 
This study presents the first application of outcome feedback 
technology in an IAPT stepped care context. The primary objective of the 
study was to evaluate the clinical impact of using OF, quantified in terms of 
changes in symptoms, treatment duration and cost. A secondary objective  
was to assess the feasibility and acceptability of discussing OF with patients 
in weekly therapy sessions. 
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2. Method 
2.1. Setting, interventions and study design 
This study was conducted in an IAPT stepped care service in Leeds, a 
large and socioeconomically diverse city in the north of England. The service 
offered evidence-based and protocol-driven psychological interventions for 
depression and anxiety problems, guided by routine session-by-session 
outcomes monitoring, consistent with clinical guidelines (National Institute  
for Health and Care Excellence, 2011). According to publicly available data 
for the period of the study (NHS Digital, 2016), 6410 cases referred to this 
service completed treatment, and this service’s performance metrics for post-
treatment reliable improvement (62.2%) were closely comparable to the 
national average (62.2%), although IAPT recovery rates (41.3%) were below 
the national average (46.3%).  
A group of 18 psychological therapists participated in the study on a 
voluntary basis. The majority (N = 14) delivered high intensity cognitive 
behavioural therapy (CBT), 2 delivered high intensity interpersonal 
psychotherapy (IPT), and 2 delivered low intensity CBT. In keeping with 
routine practice, participating therapists could be assigned any cases on 
waitlist who were assessed as suitable for their treatment modality (and step 
of care), and no other selection of cases was applied in the study. 
Participating therapists routinely reviewed their patients’ self-reported 
outcome measures (described below) at the start of every treatment session. 
This was a quasi-experimental before-and-after study (Cook & 
Campbell, 1979), with concurrent economic evaluation and qualitative 
assessment of acceptability. Anonymised clinical records were collected for 
cases treated by this team (N = 594), six months before (controls = 349) and 
six months after they started to apply OF technology (OF cases = 245). The 
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dataset included all cases that came to an end of care within a 1-year study 
period, including completers and dropouts. Mean symptom changes, 
treatment duration and cost were compared statistically between controls 
and OF cases. Furthermore, all participating therapists (minus 3 who were  
members of the research team) and a consecutive sample of 6 patients (from 
the OF cohort) participated in semi-structured qualitative interviews 
conducted by the researchers, using a standard interview topic guide  
(available as supplementary appendix). All participants provided informed 
consent, their interviews were audio recorded, transcribed verbatim and 
analysed by a qualitative researcher. Ethical approval for the study was 
provided by an NHS research ethics committee (Ref: 15/NW/0675). 
 
2.2. Outcome feedback technology 
This study applied computerised OF technology that was integrated 
into the Patient Case Management Information System (PC-MIS), which is an 
electronic clinical record keeping system routinely used by IAPT services. 
The OF tool includes a graphical display of session-to-session depression 
and anxiety scores with overlaid clinical benchmarks, which is referred to as 
expected treatment response (ETR) curves. The ETR curves represent 80% 
confidence intervals generated using growth curve modelling following the 
method proposed by Finch, Lambert and Schaalje (2001). ETR curves were 
calculated for subgroups of cases with the same baseline severity of 
depression and anxiety scores, using a large clinical dataset of cases treated 
in IAPT (see: Delgadillo, Moreea, & Lutz, 2016). The OF tool automatically 
alerted therapists about NOT cases using a ‘red signal’, if their symptoms 
surpassed the 80% upper boundary of the ETR curves, and were thus 
progressing substantially worse than other patients. 
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During the control phase of the study, therapists had access to a 
standard version of PC-MIS, which simply plots symptom severity scores on 
a weekly chart, without showing ETR curves or red signals. Before the OF 
phase, therapists attended a 6-hour training course led by authors KdJ, ML 
and JD. The training covered the OF evidence base, theory and technology, 
and primed therapists to review and discuss ETR graphs with patients at 
every treatment session and to discuss NOT cases in their clinical 
supervision meetings. 
 
2.3. Measures and data sources 
2.3.1. Quantitative outcome measures 
Patients accessing IAPT services complete two standardised outcome 
measures on a session-to-session basis to monitor response to treatment. 
The PHQ-9 is a nine-item screening tool for major depression, where each 
item is rated on a 0 to 3 scale, yielding a total depression severity score 
between 0–27 (Kroenke, Spitzer, & Williams, 2001). A cut-off ≥ 10 has been 
recommended to detect clinically significant depression symptoms (Kroenke, 
Spitzer, & Williams, 2001), and a difference of ≥6 points between 
assessments is indicative of reliable change (Richards & Borglin, 2011). The 
GAD-7 is a seven-item measure developed to screen for anxiety disorders 
(Spitzer, Kroenke, Williams, & Löwe, 2006). It is also rated using a 0 to 3 
scale, yielding a total anxiety severity score between 0–21. A cut-off score ≥8 
is recommended to identify the likely presence of a diagnosable anxiety 
disorder (Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007), and a 
difference of ≥5 points is indicative of reliable change (Richards & Borglin, 
2011). The validity and reliability of both measures have been established 
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across different countries and healthcare populations (Moriarty, Gilbody, 
McMillan, & Manea, 2015; Plummer, Manea, Trepel, & McMillan, 2016). 
 
2.3.2. Qualitative data sources 
Standard interview topic guides (available as a supplementary 
appendix) were written to conduct semi-structured interviews with 
therapists and patients, lasting up to half an hour. Each guide had a total of 
6 questions. The therapist guide aimed to explore how they used OF, their 
opinion about the technology, any obstacles to using OF, the influence it had 
on their clinical supervision and any further comments. The patient guide 
aimed to explore their experiences of outcome monitoring, the use of 
computerised technology to inform their care, and their views about how 
therapists should assess treatment progress. 
 
2.3.3. Other data sources 
Additional information included primary diagnosis recorded in clinical 
records, treatment duration (number of sessions attended), treatment 
completion status (versus dropout), employment status, disability (self-
reported: yes/no), age, gender, ethnicity and baseline functional impairment 
assessed by the Work and Social Adjustment Scale (WSAS; Mundt, Mark, 
Shear, & Griest, 2002). 
 
2.4. Sample characteristics 
Sample characteristics are presented in Table 1 for the full sample, 
and each of the two study cohorts. Overall, the sample was characterised by 
a majority of female (63.8%) patients with a mean age of 38.69 (SD = 13.87) 
and from a white British background (87.8%). Approximately 40% were 
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unemployed and 14.1% had a self-reported disability. The most frequent 
diagnoses recorded in clinical records were mixed anxiety and depressive  
disorder (40.2%), depression (28.3%), and anxiety disorders (28.3% 
including post-traumatic stress disorder, generalized anxiety, panic disorder, 
obsessive-compulsive disorder, social phobia and other specific phobias). 
Mean baseline PHQ-9, GAD-7 and WSAS estimates reported in Table 1 were  
not significantly different between cohorts (p > .05). 
 
[Table 1] 
 
2.5. Data analysis 
2.5.1. Quantitative analysis 
Changes in depression (PHQ-9) and anxiety (GAD-7) scores were 
examined using longitudinal multilevel modelling (MLM), where session-to-
session measures (level 1) were nested within cases (level 2)  treated by the  
participating therapists.  Separate models were used for each outcome 
measure, including random intercepts and random slopes at level 2.  
MLM was performed in three steps. First, an unconditional model 
with no predictors was used to assess whether a linear or non-linear 
(quadratic, cubic, log-linear) growth trend for time (treatment sessions) 
provided a better fit to the data. Goodness-of-fit was determined by 
examining the AIC statistic and using log likelihood ratio tests. Preliminary 
tests indicated that a log-linear growth trend offered the best fit to the data 
(linear trend: AIC = 20081.31, -2LL = 20077.31; log-linear trend: AIC = 
20029.02, -2LL = 20025.02; x2(1) = 52.29, p < 0.01), so these settings were 
retained in subsequent steps. Next, we adjusted the model to control for 
case-mix variables (baseline severity, functional impairment, employment 
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status, disability, age, sessions, sessions * time interaction) given the non-
randomized study design. Continuous variables were grand mean centred. 
Baseline severity was modelled using a factor score which combined all 
items from PHQ-9 and GAD-7 to reduce multicollinearity. In the third step, 
we entered a binary ‘cohort’ variable as a predictor (controls vs. OF cases) , 
as well as a cohort * time interaction term. 
Using the diagnostic cut-offs and reliable change indices for each 
outcome measure (described above), we applied Jacobson and Truax (1991) 
criteria to report the proportions of cases with reliable and clinically 
significant improvement (RCSI) and reliable deterioration during their 
stepped care treatment episode. RCSI rates, treatment dropout rates and 
total cases classed as NOT were compared between cohorts using case-mix 
adjusted logistic regression. Supplementary outcome metrics commonly 
used in IAPT services were also estimated and described, including reliable 
improvement rates (Jacobson & Truax, 1991) for each measure and IAPT 
recovery rates (Clark et al., 2009). 
Every case was assigned a treatment cost by multiplying the average 
hourly rate for each professional group (NHS pay grades: band 5, 6 and 7, 
including organisational overheads) by the total number of contact hours 
recorded in clinical records during the entire stepped care pathway. The 
mean number of treatment contacts and average direct treatment costs were 
compared between cohorts using MANOVA, which allows the values of 
multiple dependent scale variables to be modelled in a single analysis based 
on their relationships to predictors (case-mix variables). 
Each of the above analyses were applied in the full sample (N = 594), 
and repeated as secondary analyses in the subsamples of cases that were 
classed as NOT (N = 318) and OT (N = 276). 
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2.5.2. Qualitative analysis 
Qualitative interview transcripts from 15 therapists and 6 patients 
were analysed together by a primary reviewer following the six phases of 
thematic analysis described by Braun and Clarke (2006). Stage one involved 
familiarisation with all transcripts. Stage two involved ‘open coding’ through 
a line-by-line inspection of transcripts. Stage three involved clustering codes 
into potential themes through constant comparison within and across 
transcripts. Stage four involved generating a thematic map. Stage five aimed 
to refine the themes into a coherent narrative structure. Finally, stage six 
involved the selection of representative  data extracts to produce a descriptive 
account. A secondary reviewer independently analysed a subset of 
transcripts, and notes were compared between reviewers to refine the 
thematic map using a constant comparison and peer review approach 
(Angen, 2000). 
 
3. Results 
 
3.1. Quantitative data on clinical impact 
 Fixed effects of the fully adjusted MLM analysis are shown in Table 2. 
The cohort * time interaction term represents the main between-group 
comparison in symptom changes across time. This was not statistically 
significant in PHQ-9 (B = 0.80, SE = 0.78, p = 0.30) or GAD-7 (B = 0.80, SE 
= 0.71, p = 0.26) models applied in the full sample, nor in the subsamples of 
NOT (shown in Table 2) or OT cases. 
 
[Table 2] 
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Case-mix adjusted logistic regressions (Table 3) indicated that RCSI 
rates were not significantly different between controls and OF cases; PHQ-9: 
41.8% vs. 38.2%, OR = 1.01, 95% CI [0.67, 1.52], p = 0.96; GAD-7: 31.6% 
vs. 29.5%, OR = 1.20, 95% CI [0.81, 1.78], p = 0.36. The overall numbers of 
cases with reliable deterioration were too small to compare statistically; with 
19 cases in the control cohort and 6 cases in the OF cohort. No significant 
differences in dropout rates were found between controls (27.3%) and OF 
cases (27.6%); B = -0.03, SE = 0.21, p = 0.90, OR = 0.98, 95% CI [0.65, 
1.46]. Secondary analyses in NOT and OT samples across various outcome 
metrics presented in tables 3 and 4 yielded the same results as above. 
However, cases in the control cohort were significantly more likely to be 
classed as NOT by comparison to OF cases; B = 0.81, SE = 0.18, p = <0.001, 
OR = 2.25, 95% CI [1.58, 3.20].  
 
[Tables 3 and 4] 
 
 MANOVA results indicated that the mean number of treatment 
contacts in the control cohort (adjusted mean = 10.25, SE = 0.45) was 
significantly higher than the OF cohort (adjusted mean = 6.59, SE = 0.51); B 
= 3.66, SE = 0.55, p < 0.001; SMD = 3.66, 95% CI [2.58, 4.74]. This is 
illustrated in Figure 1 which displays trajectories of change (growth curves) 
in depression symptoms over time for controls and OF cases. The OF group 
has a shorter curve since the range of treatment length was between 1 to 20 
sessions, whereas the control group had a longer range between 1 and 36 
sessions. Although the confidence intervals (dashed lines) for both curves 
overlap, the figure shows a trend for lower-level symptoms in the OF group, 
which is plausibly explained by the significantly lower percentage of cases 
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classified as NOT in that group. As shown in Figure 2, the average cost of 
treatment was significantly higher for controls (adjusted mean = £246.43, SE 
= 13.24) by comparison to OF cases (adjusted mean = £148.90, SE = 14.97); 
B = 97.54, SE = 16.12, p < 0.001, SMD = £97.54, 95% CI [£65.88, £129.20]. 
The average treatment duration and cost estimates were also significantly 
higher for the control cohort in the samples of NOT (SMD: sessions = 2.77 
[1.23, 4.32]; cost = £75.65 [£29.14, £122.15]) and OT cases (SMD: sessions 
= 3.02 [1.60, 4.45]; cost = £74.56 [£34.60, £114.52]). 
 
[Figures 1 and 2] 
   
3.2. Qualitative data on feasibility and acceptability  
Three overarching themes emerged through constant comparison of 
qualitative interview transcripts; these are described below with reference to 
participant quotes (where T = therapist, P = patient).   
 
Theme 1: Implementing outcome feedback (OF) 
 
Most therapists discussed the rationale behind OF at the first or 
second therapy session, and they tended to review Expected Treatment 
Response (ETR) charts at the start of every session. This practice was 
corroborated by the majority of patients [5 of 6] who reported that OF was 
used on a weekly basis.  
"every week the item on the agenda was always checking in 
with my current mood on that day so we sort of –you know– 
looked at how I was feeling, literally within five minutes of the 
session." P6, 9-11.  
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This process prompted therapists to raise problem solving 
conversations related to NOT signals, but also to motivate and reinforce 
positive change when patients’ symptoms were on track. A few therapists 
reported reviewing ETR charts with patients at less frequent intervals, such 
as every 4 to 6 weeks. 
Therapists reported that ETR charts alerted them to unnoticed 
difficulties and enabled them to review their treatment plan in collaboration 
with patients.  
"There were a couple of occasions where it highlighted to both 
of us really that the treatment we were doing –although it was 
useful for them– it wasn't as effective as it could be, so it 
meant that we could change very quickly what we were 
doing." T12, 49-51.  
 
The ETR charts were seen as a helpful tool to support and sometimes 
to correct clinical judgement.  
“It's been a useful tool in getting me to think… I can sometimes 
blindly continue thinking ‘this is going to work, we'll get some 
effect’, and it's allowed me to say actually say no – we need to 
take stock” T3, 116-123.  
 
One patient indicated that OF gave their therapist an insight into 
what was working and highlighted which aspects of therapy to focus on. 
“It helped [the therapist] know where we were going with our 
sessions and it helped me understand what was working and 
what wasn’t” P1, 30-33. 
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Therapists also reported using ETR charts to reflect about treatment 
progress and to inform treatment planning within clinical supervision 
meetings. Some therapists stated that this method prompted them to 
discuss some cases in clinical supervision earlier than they would normally 
do, and sometimes prompted decisions to ‘step patients up’ to more 
intensive treatments. A few therapists also stated that they were using ETR 
charts to inform their professional development plans as part of clinical 
supervision meetings. 
“We pull up the graph, go into the client's record and see what 
their progress has been like. And from then my supervisor will 
ask me if there have been any potential barriers, anything that 
got in the way of the client progressing on track as we would 
hope to expect, and it helps me to be able to reflect” T12 160-
168.  
 
Theme 2: Experiences and acceptability 
 Therapists found the ETR charts and system easy to use, compatible 
with usual outcome monitoring in IAPT, and they were able to integrate it 
within sessions without much difficulty. 
“It's really handy, it's simple that's the good thing. As a user 
you can look at it and spot things quickly” T2, 65-69.  
 
Most patients also found it interesting and useful.  
“It's definitely a useful tool because sometimes you don't 
realise you've made progress, but if you've got something on 
screen showing you what your scores were and what they are, 
it quantifies your progress” P4, 74-78.  
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One exception was reported by a patient accessing low intensity CBT 
(30 minute sessions) who felt it took up too much time .  
“I wouldn't have minded ten minutes of an hour, but ten 
minutes of half an hour is… it cuts your time down, my time 
down” P3, 53-56. 
  
Many therapists described how OF helped to involve and engage patients, 
thereby enhancing collaboration.  
“For me the biggest thing is about the increase in the 
collaboration with yourself and the patient, also creating a 
transparency of what these measures are for, I found that 
helpful, and it boosts the relationship” T13; 149-150.  
 
Some patients also suggested that reviewing ETR charts prompted therapists 
to enable them to reflect and gain insights about their problems.  
“My therapist was really good at picking out and getting me to 
talk about stuff that –um you know– that came to mind –you 
know– that I hadn't realised before I did it” P2, 30-31.  
  
Therapists at times felt that having conversations about NOT signals could 
be daunting; but at other times they found that the ETR system gave them 
confidence to raise difficult issues. 
“It's just given me a bit more confidence that it's okay to have 
those difficult conversations with people” T15, 137-142.  
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It was also reported that reviewing ETR graphs can boost therapists’ 
confidence and provide reassurance about their practice when cases were on 
track. 
 
Theme 3: Challenges and solutions 
 Therapists described a series of challenges that they encountered as 
they started to implement OF in routine practice. Some challenges were of a 
technical nature (i.e., lack of computer in clinic room), which were possible 
to resolve by printing ETR graphs in advance of sessions. Other challenges 
related to explaining to patients how ETR boundaries were calculated in 
order to clarify the rationale for OF.  
“The only difficulty I found is trying to explain how we come up 
with the status. What I’ve been saying to people is [that] we use 
data for people who started at the same score as you” T3, 62-64. 
 
Some therapists raised examples of patients who did not like filling in 
questionnaires, and others who did not complete them accurately. A 
common theme in these discussions was the importance of how ETR charts 
are explained to patients in order to foster collaboration with the OF method. 
Therapists reflected on the importance of using lay terminology to explain 
the rationale for OF, and using non-threatening language when discussing 
NOT signals. 
“I think the most difficult thing was how we describe it to 
patients without putting too much emphasis on the expected 
treatment outcomes. […] Just trying to say ‘this is the average’ 
rather than ‘this is what we expect’ because I don’t want 
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people to feel they’re not meeting the expectations” T12, 65-
69. 
 
4. Discussion 
 
4.1. Main findings 
 This study presents the first comprehensive evaluation of outcome 
feedback technology applied in a stepped care psychological treatment 
setting. The results indicated that this technology was feasible to adopt in 
routine care, was minimally burdensome, and was generally seen by 
therapists and patients as a useful aid to decision-making and clinical 
supervision processes.  
Qualitative interviews with therapists revealed that the outcome 
feedback signalling technology influenced their interpretation and use of 
routine outcomes data in a number of ways: they openly discussed outcomes 
data with patients more consistently; they tended to take notice of obstacles 
to improvement much sooner than usual; they prioritised NOT cases in 
clinical supervision meetings; they were more open to the possibility that 
their clinical impressions may be incorrect or in need of revision and 
consequently they were also more open to reconsider their treatment plan. 
Therapists also stated that they felt more confident in explaining the 
rationale of outcome monitoring to their patients and in discussing and 
addressing potential problems, which they felt enhanced collaboration. 
Furthermore, although quantitative data on the frequency of these outcome 
monitoring discussions were not collected, the qualitative interviews 
reflected a remarkable consistency in therapists’ and patients’ accounts of 
the regular and collaborative use of outcome feedback. Some individual 
differences were also apparent in therapists’ way of explaining ETR charts 
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and the frequency with which they discussed these with patients. Overall, 
and considering that this group of therapists had years of experience 
collecting and reviewing outcome measures, the OF signalling technology 
made outcome monitoring a more salient, informative and collaborative 
aspect of the treatment process. 
The integration of routine outcome monitoring in IAPT stepped care 
services (Clark, 2011) is likely to have supported a culture and 
infrastructure that is open to innovations like ETR technology. This 
technical and cultural readiness may explain the ease of adoption reflected 
in this study, which stands in contrast to previous efforts to implement 
feedback methods in psychotherapy services that are less accustomed to 
routine outcome monitoring (e.g., Gleacher et al., 2016; Lucock et al., 2015). 
 Quantitative analyses revealed that applying OF technology yielded 
similar outcomes to usual care, but within fewer sessions and at lower cost, 
considerably enhancing the efficiency of treatment. Furthermore, control 
cases were twice as likely to be classed as NOT by comparison to OF cases 
(OR = 2.25). The standardised mean difference (cost saving) for an average  
treatment was approximately £97.54 [£65.88, £129.20]. Taking the 
conservative lower bound of the confidence interval (£65.88) and multiplying 
this by the total of 245 OF cases equates to an estimated cost saving of 
£16,140.60 in the treatment of that cohort of patients within 6 months. This 
converges with a recent study that also found OF to yield similar outcomes 
more efficiently in CBT interventions (Janse, De Jong, Van Dijk, 
Hutschemaekers, & Verbraak, 2017). This replication of findings indicates 
that using OF technology can enhance the efficiency of psychological care in 
settings where protocol-driven CBT is a predominant treatment model. 
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 Current wisdom in the field suggests that OF is specifically helpful for 
a subset of signal cases that are classified as NOT during therapy (Carlier et 
al., 2012; Castonguay, Barkham, Lutz, & McAleavey, 2013; Knaup, Koesters, 
Schoefer, Becker, & Puschner, 2009; Shimokawa, Lambert, & Smart, 2010). 
In fact, some reviews that examine controlled trials of feedback in full 
samples (rather than subsamples of NOT cases) fail to detect the effects that 
are typically observed in these studies (Kendrick et al., 2016). Contrary to 
findings reported in most reviews, we found no evidence of differential effects 
of feedback on the clinical outcomes of NOT cases. It is possible that the 
standard outcome monitoring technology that supported the treatment of 
control cases could already be working as a useful feedback tool, possibly 
explaining the lack of differences in clinical outcomes between-groups. It is 
also apparent that using OF technology considerably reduces the chances of 
being classed as NOT during treatment; hence another explanation is that 
the few cases classed as NOT in the OF cohort could be those which are 
generally unresponsive to psychological interventions.  
The confluence of qualitative and quantitative evidence in this study 
suggests that feedback in this setting may work by alerting therapists to 
identify and to resolve obstacles sooner, thus accelerating the recovery 
process for cases that are amenable to therapeutic improvement, as well as 
by providing an earlier signal to ‘step up’ cases that are clearly not 
responding to treatment. An alternative explanation could be that the 
training and emphasis that the study placed on regular review of outcome  
measures in clinical sessions and supervision meetings may account for the  
observed effect, regardless of the specific effect of NOT signals. It should be  
noted that the study design did not enable us to isolate the specific influence 
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of NOT signals and to disentangle this from more conventional aspects of 
diligent and collaborative outcome monitoring. 
 
4.2. Strengths and limitations 
 The large sample size of cases treated in a routine care context and 
intention-to-treat approach to analyses enhance the external validity of the 
study. The before-and-after design also enabled us to minimise confounding 
due to therapist effects, since each therapist was his/he r own control. 
However, the lack of random allocation and the use of historical controls 
raise some threats to internal validity. We cannot rule out the possibility 
that unmeasured external influences (i.e., policy, managerial or practice 
changes) could have influenced the length of interventions. An important 
caveat to our findings is that this self-selected group of therapists may be 
particularly motivated to apply OF in a way that may not be representative of 
the wider IAPT programme workforce. Furthermore, we only interviewed a 
small number of patients, who may not be representative of the wider 
clinical population. A larger-scale, multi-service randomised controlled trial 
is necessary to gain a more rigorous and generalizable view about the impact 
of feedback and the degree to which IAPT services are ‘ready’ to adopt these 
methods in routine care. Future studies could also assess outcomes using 
different outcome measures to those used as part of the feedback process to 
assess the extent to which tracking generic anxiety measures like GAD-7 
impacts on outcomes assessed using disorder-specific measures for 
conditions like post-traumatic stress disorder, obsessive compulsive 
disorder, panic disorder, etc. 
A further limitation is that this study did not collect follow-up data 
after the end of the acute phase of treatment, so it is unclear whether the  
apparent benefits of treatment are durable in the long run. We do not know, 
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from the available data, if patients in the OF condition may have been 
discharged from therapy shortly after attaining remission of symptoms, or if 
some treatment sessions after initial remission were appropriately devoted to 
relapse prevention in order to maintain longer-term gains. The growth curve  
corresponding to the OF sample in Figure 1 clearly decelerates (flattens) 
between sessions 15 and 20, which would indicate a trend of ongoing 
treatment sessions after average remission of symptoms. This suggests that 
treatment continued for some time after initial remission of symptoms in the 
OF group (possibly devoted to consolidating gains and relapse prevention, 
although we did not have data on session content); whereas treatment 
continued for considerably longer in control group cases that were 
apparently unresponsive to treatment. An important direction for future 
research is to investigate longer-term remission and relapse rates after brief 
psychological interventions assisted by outcome feedback technology, to 
ensure that apparent gains in efficiency do not come at the expense of 
longer-term relapse. 
 
4.3. Conclusions 
 Outcome feedback technology was feasible to implement in routine 
practice, it was generally acceptable  to therapists and patients, and was 
associated with improved efficiency and reduced costs of stepped care 
psychological treatment. The gains in efficiency could enable therapists to 
invest additional time and effort in relapse prevention to maximise long-term 
recovery for those who respond to treatment. Conversely, cases that are 
clearly not responding to treatment can be detected using OF and 
appropriately stepped up sooner, as per stepped care guidelines. 
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Table 1. Sample characteristics 
 
 
 
 Full sample  Cohort 1: controls  Cohort 2: OF cases 
 (N = 594)  (N = 349)  (N = 245) 
Demographics 
Mean age (SD) 38.69 (13.78)  38.49 (13.65)  38.96 (13.99) 
Females (%) 63.8  62.5  65.7 
White British (%) 87.8  87.9  87.6 
Unemployed (%) 40.0  39.8  40.2 
Disabled (%) 14.1  13.1  15.5 
Primary diagnosis 
Depression (%) 28.3  26.1  31.2 
Anxiety disorder (%) 28.3  31.7  23.8 
*Mixed Anx & Dep (%) 40.2  39.2  41.5 
Eating disorder (%) 2.1  2.6  1.5 
Somatoform disorder (%) 1.1  0.4  2.0 
Baseline severity of symptoms and functioning 
Mean PHQ-9 (SD) 14.42 (6.33)  14.59 (6.26)  14.17 (6.42) 
Mean GAD-7 (SD) 12.87 (5.40)  13.17 (5.35)  12.43 (5.46) 
Mean WSAS (SD) 20.02 (9.17)  20.52 (9.07)  19.30 (9.28) 
Notes: * mixed anxiety and depressive disorder; OF = outcome feedback; SD = standard deviation; PHQ-9 = 
depression severity; GAD-7 = anxiety severity; WSAS = functional impairment 
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Table 2. Longitudinal multilevel modelling comparing outcome changes between controls and OF cases 
 
 
 
  Fixed effects 
  Full sample (N = 594)  NOT sample (N = 318) 
Outcome Variable B SE p  B SE p 
PHQ-9 Intercept 17.70 0.68 <0.001  18.82 0.78 <0.001 
 Time (Log) -7.34 0.66 <0.001  -6.86 0.87 <0.001 
 Age -0.02 0.01 0.26  0.00 0.02 0.81 
 Factor score 2.93 0.24 <0.001  3.12 0.29 <0.001 
 WSAS 0.15 0.03 <0.001  0.13 0.03 <0.001 
 Employed (vs. unemployed) -0.46 0.40 0.25  -0.49 0.45 0.28 
 Not disabled (vs. disabled) -1.90 0.61 <0.01  -1.19 0.66 0.07 
 Cohort(1) (vs. 2) 0.07 0.50 0.89  -0.80 0.62 0.20 
 Cohort * Time 0.80 0.78 0.30  0.82 1.00 0.41 
 Sessions 0.06 0.04 0.14  0.01 0.05 0.84 
 Sessions * Time 0.06 0.06 0.35  0.02 0.08 0.75 
GAD-7 Intercept 15.12 0.61 <0.01  16.04 0.69 <0.001 
 Time (Log-linear) -6.65 0.60 <0.01  -6.25 0.81 <0.001 
 Age -0.03 0.01 0.03  -0.01 0.01 0.49 
 Factor score 2.59 0.22 <0.01  2.66 0.25 <0.001 
 WSAS 0.08 0.02 0.00  0.05 0.03 0.04 
 Employed (vs. unemployed) -0.35 0.36 0.34  -0.38 0.39 0.33 
 Not disabled (vs. disabled) -1.08 0.55 0.05  -0.11 0.57 0.85 
 Cohort(1) (vs. 2) 0.21 0.45 0.64  -0.23 0.55 0.67 
 Cohort * Time 0.80 0.71 0.26  0.44 0.93 0.63 
 Sessions 0.11 0.04 <0.01  0.01 0.04 0.84 
 Sessions * Time 0.02 0.06 0.79  0.02 0.07 0.77 
Notes: NOT = not on track; SE = standard error; PHQ-9 = depression severity; GAD-7 = anxiety severity; WSAS = 
functional impairment; Cohort 1 = controls; Cohort 2 = OF cases; all continuous measures were grand mean centred; 
main hypothesis test in bold text 
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Table 3. Logistic regressions comparing outcomes between controls and OF cases 
 
 
 
  Full sample (N = 594)  NOT sample (N = 318) 
Outcome Variable B SE p OR  B SE p OR 
PHQ-9 RCSI    
 Age 0.01 0.01 0.49 1.01  0.01 0.01 0.50 1.01 
 Factor score -0.25 0.15 0.10 0.78  -0.16 0.19 0.40 0.85 
 WSAS -0.03 0.01 0.03 0.97  -0.04 0.02 0.05 0.96 
 Disabled (vs. not disabled) -0.72 0.34 0.03 0.49  -0.49 0.40 0.23 0.61 
 Unemployed (vs. employed) -0.39 0.21 0.06 0.68  -0.36 0.27 0.19 0.70 
 Cohort 2 (vs. 1) 0.01 0.21 0.96 1.01  -0.06 0.29 0.84 0.95 
 Constant 0.46 0.44 0.30 1.58  0.47 0.56 0.40 1.60 
GAD-7 RCSI    
 Age 0.01 0.01 0.25 1.01  0.01 0.01 0.43 1.01 
 Factor score -0.14 0.14 0.33 0.87  -0.14 0.18 0.43 0.87 
 WSAS -0.05 0.01 0.00 0.95  -0.06 0.02 0.00 0.95 
 Disabled (vs. not disabled) -0.61 0.32 0.06 0.54  -0.49 0.40 0.22 0.61 
 Unemployed (vs. employed) -0.46 0.21 0.03 0.63  -0.52 0.27 0.05 0.59 
 Cohort 2 (vs. 1) 0.19 0.20 0.36 1.20  0.28 0.28 0.31 1.32 
 Constant 0.74 0.43 0.08 2.09  0.77 0.54 0.15 2.15 
Dropout    
 Age -0.02 0.01 <0.001 0.98  -0.02 0.01 0.11 0.98 
 Factor score -0.04 0.13 0.78 0.97  0.14 0.18 0.43 1.15 
 WSAS 0.02 0.01 0.12 1.02  0.02 0.02 0.27 1.02 
 Disabled (vs. not disabled) -0.03 0.31 0.92 0.97  0.33 0.38 0.39 1.39 
 Unemployed (vs. employed) 0.42 0.20 0.04 1.52  0.31 0.27 0.25 1.36 
 Cohort 2 (vs. 1) -0.03 0.21 0.90 0.98  0.02 0.29 0.94 1.02 
 Constant -0.27 0.20 0.18 0.76  -1.08 0.58 0.06 0.34 
% Cases classified as NOT    
 Age 0.00 0.01 0.59 1.00      
 Factor score 0.06 0.11 0.58 1.06      
 WSAS 0.02 0.01 0.07 1.02      
 Disabled (vs. not disabled) 0.04 0.27 0.89 1.04      
 Unemployed (vs. employed) 0.03 0.18 0.88 1.03      
 Cohort 1 (vs. 2) 0.81 0.18 <0.001 2.25      
 Constant 0.20 0.39 0.60 1.23      
Notes: NOT = not on track; SE = standard error; OR = odds ratio; PHQ-9 = depression severity; GAD-7 = anxiety severity; WSAS = functional 
impairment; Cohort 1 = controls; Cohort 2 = OF cases; RCSI = reliable and clinically significant improvement; main hypothesis test in bold 
text 
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Table 4. Summary of clinical outcomes in controls and OF cases  
 
 
 Full sample (N = 594)  NOT sample (N = 318) 
Outcomes Cohort 1 (controls) Cohort 1 (OF cases)  Cohort 1 (controls) Cohort 1 (OF cases) 
Pre- Mean PHQ-9 (SD) 14.59 (6.26) 14.17 (6.42)  15.31 (5.86) 16.63 (5.86) 
Post- Mean PHQ-9 (SD) 10.84 (7.48) 11.05 (7.03)  11.13 (7.38) 12.60 (7.57) 
Pre- Mean GAD-7 (SD) 13.17 (5.35) 12.43 (5.46)  14.31 (4.72) 14.68 (5.09) 
Post- Mean GAD-7 (SD 9.43 (6.13) 9.56 (5.95)  9.85 (5.88) 10.86 (6.60) 
PHQ-9 RCSI (%) 41.8 38.2  42.1 34.4 
PHQ-9 RI (%) 49.9 47.6  48.6 43.1 
PHQ-9 RD (%) 5.6 2.6  6.5 4.9 
GAD-7 RCSI (%) 31.6 29.5  39.2 38.4 
GAD-7 RI (%) 50.1 48.5  50.5 47.1 
GAD-7 RD (%) 4.4 2.6  5.1 3.9 
IAPT recovery (%) 50.8 44.9  50.3 42.0 
Notes: SD = standard deviation of the mean; NOT = not on track; PHQ-9 = depression severity; GAD-7 = anxiety severity; RCSI = reliable and 
clinically significant improvement; RI = reliable improvement; RD = reliable deterioration; IAPT recovery = cases where at least one measure 
(PHQ-9 or GAD-7) was in the clinical range at baseline and where both measures were below the clinical cut -offs post-treatment 
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Figure 1.  
Trajectories of change in depression symptoms comparing controls and Outcome Feedback (OF) cases 
 
 
 
 
  
Cohort 1: Controls  [range: 1 – 36 sessions] 
Cohort 2: OF cases [range: 1 – 20 sessions] 
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Figure 2.  
Standardised mean difference (SMD) in treatment costs between controls and OF cases 
 
 
 
